415 Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Cardiac Successcardiacsuccess.comJun 2021 · $5.2M
Cardiac Success develops a transcatheter ventricular remodeling device to treat patients with heart failure with reduced ejection fraction (HFrEF) by reshaping the dilated left ventricle.
BiotechHealthtechMedical Devices
Dr. Shimon Eckhouse(Chairman & Co-Founder)David Neustadter, PhD(CTO & Founder)Boaz Manash(CEO)
PartnerFrederik Groenewegen· led
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.